Generium signed an agreement with Oxford Immunotec Farmline


29 March 2019
https://vademec.ru/

“We have signed a contract with Oxford Immunotec, a leading global immunodiagnostics company from the UK. Our basic and first joint project with the British is the collaboration on the brand called T-Spot. This is a sophisticated technology protected by a patent, which we localize in the territory of the Russian Federation,” Dmitry Kudlay, Director General of Generium, told Vademecum. “Our cooperation will significantly reduce the cost of the test system.”